Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ XN+~g.0
'9O4$s1
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© \^=Wp'5R
px `o.%`'
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© (N63k1M
z
D&5R/I
1.Co-stimulators (or co-stimulating molecules) s{IXth6
VU~
R
2.NK-kB
+n#kpi'T
'FVh/};Y.D
3.Immunoglobulin superfamily '3
B\
I#
EP!zcp2' C
4.antigen-presenting cell (APC) rLt`=bl&&U
?|Q[QP
5.death domain Jxyeh1zqB
Z^P]-CB|6A
6.CCR and CXCR B.:DW3
T(<
[k:`
7.Lectin (or mitogen) .23z\M8
-
+f#o
ij
8.Clusters of differentiation, CD) -N'xQ(#n3q
l| /tKW
9.B7 family '
KX'{Gy
PQ}q5?N
10.Cytotoxic T lymphocyte, CTL) |~QHCg<
#Y)Gos
11.IL-15 and IL-15 receptor (IL-15R) `O:ecPD4M
)s @}|`
12.MHC restriction {Q/XV=
K YSyz)M}
13.Affinity-chromatography yrp;G_
v37TDY3;
14.Cyctosprin A, CsA [&6VI?
zn5U(>=c
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ~;m3i3D
Equj[yw%@
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© }sbh|#
jacp':T
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 *aE/\b
9qhX\, h
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ f-w-K)y$ht
?CaMn b8
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ .@#GNZe
Td7f
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© zz4TJ('
H9@24NFb
ÃâÒßѧרҵ£º pZpAb+
>";I3S-t
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ h92'~X36
U
Bo[iZ|%
Ïû»¯ÄÚ¿Æ£º qDMVZb-(#
4Nz@s^9
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ [Pn(d[$z
xWZ87
ѪҺ²¡Ñ§×¨Òµ£º Y|*a,H"_
|)"`v'8>
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿